#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diabetes insipidus Peritoneal mesothelioma malignant Follicular lymphoma stage II Mantle cell lymphoma recurrent MELAS syndrome Spina bifida Alexander disease Craniocerebral injury Hepatitis B Mitochondrial encephalomyopathy Angiosarcoma non-metastatic Mucopolysaccharidosis II Adenocarcinoma pancreas Arrhythmogenic right ventricular dysplasia Langerhans' cell histiocytosis More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Treatment Idiopathic inflammatory myopathy – Trials in Disease MELAS syndrome – Basic Information Retinoblastoma – Treatment Hairy cell leukaemia recurrent – Life with Disease Pemphigoid – Treatment Osteosarcoma metastatic – Basic Information Acute respiratory distress syndrome – Life with Disease Adrenocortical carcinoma – Treatment Testicular leiomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ruzasvir VOXVOGANAN Colestyramine Zimberelimab Pabinafusp Alfa Phenylalanine Aluminium Oxide Metolazone Goserelin Acetate GSK5460025A Nicotine Resinate Lenzumestrocel Donidalorsen GSKVX000000039711 Valine Epoetin Alfa Futibatinib Sodium S-Lactate Solution Betamethasone Acetate Cetirizine More therapies…

    Learn about Your Condition

    Colon cancer stage IV Fungal infection Thyroid cancer Hypoaesthesia Peripheral spondyloarthritis Hyperoxaluria Peripheral artery stenosis Diabetic ketoacidosis Vascular dementia Ebola disease Strongyloidiasis Congenital myopathy Ewing's sarcoma metastatic Nasopharyngeal cancer Hypertriglyceridaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Faricimab for Patients with Neovascular Age-Related Macular Degeneration Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Faricimab
    Austria

  • Study on Insulin Eye Drops for Treating Dry Eye in Patients Using Topical Hypotensors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Benzalkonium Chloride
    • Hypromellose
    • Insulin Human
    Spain

  • Study on the Use of 68Ga-NODAGA-RGD for Monitoring Treatment in Patients with Age-Related Macular Degeneration

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • 5-[4-[(2S,5S,11S,14R)-14-Benzyl-11-(Carboxymethyl)-5-[3-(Diaminomethylideneamino)Propyl]-3,6,9,12,15-Pentaoxo-1,4,7,10,13-Pentazacyclopentadec-2-Yl]Butylamino]-2-[4,7-Bis(Carboxymethyl)-1,4,7-Triazonan-1-Yl]-5-Oxopentanoic Acid Radioallebled With Gallium-68
    France

  • Study on the Effectiveness and Safety of Insulin, Ciclosporin, and Benzalkonium Chloride in Patients with Moderate to Severe Dry Eye Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Benzalkonium Chloride
    • Hypromellose
    • Ciclosporin
    Spain

  • Study on the Effectiveness and Safety of Hydrocortisone Sodium Phosphate for Patients with Dry Eye and Moderate Meibomian Gland Dysfunction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    Spain

  • Study on Low-Dose Atropine Sulfate Eye Drops for Controlling Progressive Myopia in Caucasian Children

    Not recruiting

    3 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate
    Germany
Previous Page
1 … 34 35 36 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!